NEW - Peer-reviewed, large PSM study from Brazil finds, "regular use of ivermectin as a prophylactic agent was associated with significantly reduced COVID-19 infection, hospitalization, and mortality rates."
The study was published in the Cureus Journal of Medical Science today:
